ClinVar Miner

Submissions for variant NM_013447.4(ADGRE2):c.1805T>C (p.Ile602Thr)

gnomAD frequency: 0.00001  dbSNP: rs534741485
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Mendelics RCV002248988 SCV002516253 benign not specified 2022-05-04 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV003728051 SCV004534496 uncertain significance not provided 2024-02-10 criteria provided, single submitter clinical testing This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 602 of the ADGRE2 protein (p.Ile602Thr). This variant is present in population databases (rs534741485, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with ADGRE2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1685261). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.